BML-277 BML-277游离态
CAS 516480-79-8 MFCD08276917
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Bioactives/Supplements, C-CH, Cell Biology, Cell Signaling and Neuroscience, Checkpoint Kinase (ChK), General Stem Cell Biology, Inhibitors, Johnson & Johnson, Kinase/Phosphatase Biology, Protein Kinase Inhibitors, Serine/Threonine Kinase Biology, Serine/Threonine Kinase Inhibitors, Stem Cell Biology, Stem Cell Differentiation
- {SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Bioactives/Supplements, C-CH, Checkpoint Kinase (ChK), General Stem Cell Biology, Inhibitors, Johnson & Johnson,
相关文献及参考
- Arienti, Kristen L. et al., Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles. J. Med. Chem. 48 , 1873 - 1885 , (2005)